Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
88pct
21d open
vs 5,086 other S bills in the 116th — cohort avg 30d
Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act This bill extends until May 6, 2021, the temporary scheduling order issued by the Drug Enforcement Administration to place fentanyl-related substances in schedule I of the Controlled Substances Act. The temporary order expires on February 6, 2020. Additionally, the bill directs the Government Accountability Office to study and report on the classification of fentanyl-related substances as schedule I controlled substances, research on fentanyl-related substances, and the importation of fentanyl-related substances into the United States.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (9)
Became Public Law No: 116-114.
Became Public Law No: 116-114.
Signed by President.
Signed by President.
Presented to President.
Presented to President.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 320 - 88 (Roll no. 32). (text: CR H647)
HousePassed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 320 - 88 (Roll no. 32).
HouseConsidered as unfinished business. (consideration: CR H701-702)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2021 · first_quarter · Health Issues
S.3548, CARES Act: To provide emergency assistance and health care response for individuals, families, and businesses affected by the 2020 coronavirus pandemic; Practice Support/Grants to Practice S.3599, Healthcare Workforce Resilience Act: Foreign physician immigration status H.R. 7059, Coronavirus Provider Protection Act: Liability protection for healthcare providers Public Law No: 116-142, Paycheck Protection Program Flexibility Act of 2020 S.3201, Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act: Letter to Congressional Leadership regarding Fentanyl S.2723, Mitigating Emergency Drug Shortages Act: reducing drug shortages H.R. 3502, Protecting People From Surprise Medical Bills Act: Surprise Medical Bills H.R. 2500, National Defense Authorization Act for Fiscal Year 2020: Krishnamoorthi amdt on drug shortages H.R. 3107, Improving Seniors' Timely Access to Care Act of 2019: pre-authorization S. 1895, Lower Health Care Costs Act H.R. 3692, Addiction Treatment Access Improvement Act of 2017: Medically assisted treatment; opioids H.R. 5761, Ending Maternal Mortality Act of 2018: Maternal mortality H.R. 5718, Perioperative Reduction of Opioids Act: Opioids H.R. 5197, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S. 2516, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S.2680, Opioid Crisis Response Act of 2018: Medically assisted treatment; opioids S.2456, CARA 2.0 Act of 2018: Medically assisted treatment; opioids H.R. 1565, Saving Lives, Saving Costs S.1475, Saving Lives, Saving Costs S.4349, Dr. Lorna Breen Health Care Provider Protection Act: physician health Comprehensive Addiction and Recovery Act of 2016 (PL 114-198) FY 2021 LHHS Appropriations: Fiscal Year 2021 Appropriations for Subcommittee on Labor, Health and Human Services Outside Witness Testimony Affordable Care Act reform efforts H.R. 1628, American Health Care Act of 2017 S. Amdt. 1030 to H.R. 1628, "Graham-Cassidy" Better Care Reconciliation Act of 2017 H.R. 1492, Medical Controlled Substances Transportation Act of 2017 H.R. 1215, Protecting Access to Care Act of 2017 H.R. 3545, Overdose Prevention and Patient Safety Act H.R. 3446, Restoring Board Immunity Act of 2017: Professional Licensing S.2260, Opioids and STOP Pain Initiative ACT:opioids 42 CFR Part 2, Confidentiality of Substance Use Disorder Patient Records: appropriate access to patient information essential for providing whole-person care H.R.3928, Truth in Healthcare Marketing Act of 2017 H.R. 1554, REDI Act: student loan debt repayment for residents H.R.842, Protecting the Right to Organize Act of 2021: PRO Act, labor protections 21st Century Cures Initiative Drug Shortages - FDA, DEA, HHS, CMS, GAO, House Energy and Commerce Committee, Senate HELP Committee DEA Scheduling Propofol Comparative Effectiveness Research - PCORI HITECH Implementation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Safe Use Initiative Pain Management FTC Letters to States re: Interventional Pain Medicine & Advanced Practice Nurses & Competition in Healthcare Anesthesia Research Funding (Pediatric and others) Scope of Practice FDA Operating Room Fires Naloxone FDA Opioids Prescription Drug Abuse FDA Network of Experts NIH Interagency Pain Research Coordinating Committee FDA SMART TOTS - pediatric anesthesia research USP - US Pharmacopeia National Pain Strategy Nondiscrimination Compounding FDA Nominations to Advisory Committees (Anesthesia Drugs, Anesthesia Devices, Compounding) Agency for Healthcare Research and Quality (AHRQ) funding Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Sequestration Opioids and opioid abuse; Brain health Certified Anesthesiologist Assistants Blood management COVID-19: Increased supply of PPE and ventilators, Funding for physician practices impacted by the cancellation of elective surgeries, unique role of anesthesiologists in responding to COVID-19 pandemic, medical liability, Scope of Practice (Waiver of federal supervision requirement under the Emergency Declaration), insurance moratorium; COVID Update Memorandum 4/21/20 Centre for Clinical and Applied Services Provision Research
Client expense: $260,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
2020 · fourth_quarter · Health Issues
S.3548, CARES Act: To provide emergency assistance and health care response for individuals, families, and businesses affected by the 2020 coronavirus pandemic; Practice Support/Grants to Practice S.3599, Healthcare Workforce Resilience Act: Foreign physician immigration status H.R. 7059, Coronavirus Provider Protection Act: Liability protection for healthcare providers Public Law No: 116-142, Paycheck Protection Program Flexibility Act of 2020 S.3201, Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act: Letter to Congressional Leadership regarding Fentanyl S.2723, Mitigating Emergency Drug Shortages Act: reducing drug shortages H.R. 3502, Protecting People From Surprise Medical Bills Act: Surprise Medical Bills H.R. 2500, National Defense Authorization Act for Fiscal Year 2020: Krishnamoorthi amdt on drug shortages H.R. 3107, Improving Seniors' Timely Access to Care Act of 2019: pre-authorization S. 1895, Lower Health Care Costs Act H.R. 3692, Addiction Treatment Access Improvement Act of 2017: Medically assisted treatment; opioids H.R. 5761, Ending Maternal Mortality Act of 2018: Maternal mortality H.R. 5718, Perioperative Reduction of Opioids Act: Opioids H.R. 5197, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S. 2516, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S.2680, Opioid Crisis Response Act of 2018: Medically assisted treatment; opioids S.2456, CARA 2.0 Act of 2018: Medically assisted treatment; opioids H.R. 1565, Saving Lives, Saving Costs S.1475, Saving Lives, Saving Costs S.4349, Dr. Lorna Breen Health Care Provider Protection Act: physician health Comprehensive Addiction and Recovery Act of 2016 (PL 114-198) FY 2021 LHHS Appropriations: Fiscal Year 2021 Appropriations for Subcommittee on Labor, Health and Human Services Outside Witness Testimony Affordable Care Act reform efforts H.R. 1628, American Health Care Act of 2017 S. Amdt. 1030 to H.R. 1628, "Graham-Cassidy" Better Care Reconciliation Act of 2017 H.R. 1492, Medical Controlled Substances Transportation Act of 2017 H.R. 1215, Protecting Access to Care Act of 2017 H.R. 3545, Overdose Prevention and Patient Safety Act H.R. 3446, Restoring Board Immunity Act of 2017: Professional Licensing S.2260, Opioids and STOP Pain Initiative ACT:opioids 42 CFR Part 2, Confidentiality of Substance Use Disorder Patient Records: appropriate access to patient information essential for providing whole-person care H.R.3928, Truth in Healthcare Marketing Act of 2017 H.R. 1554, REDI Act: student loan debt repayment for residents 21st Century Cures Initiative Drug Shortages - FDA, DEA, HHS, CMS, GAO, House Energy and Commerce Committee, Senate HELP Committee DEA Scheduling Propofol Comparative Effectiveness Research - PCORI HITECH Implementation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Safe Use Initiative Pain Management FTC Letters to States re: Interventional Pain Medicine & Advanced Practice Nurses & Competition in Healthcare Anesthesia Research Funding (Pediatric and others) Scope of Practice FDA Operating Room Fires Naloxone FDA Opioids Prescription Drug Abuse FDA Network of Experts NIH Interagency Pain Research Coordinating Committee FDA SMART TOTS - pediatric anesthesia research USP - US Pharmacopeia National Pain Strategy Nondiscrimination Compounding FDA Nominations to Advisory Committees (Anesthesia Drugs, Anesthesia Devices, Compounding) Agency for Healthcare Research and Quality (AHRQ) funding Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Sequestration Opioids and opioid abuse; Brain health Certified Anesthesiologist Assistants Blood management COVID-19: Increased supply of PPE and ventilators, Funding for physician practices impacted by the cancellation of elective surgeries, unique role of anesthesiologists in responding to COVID-19 pandemic, medical liability, Scope of Practice (Waiver of federal supervision requirement under the Emergency Declaration), insurance moratorium; COVID Update Memorandum 4/21/20 Centre for Clinical and Applied Services Provision Research
Client expense: $410,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
2020 · third_quarter · Pharmacy
Issues related to prescription drug importation, H.R. 5663 - the Safeguarding Therapeutics Act, S. 3201 - which extends the DEA's temporary scheduling of fentanyl-related substances; S. 4225 - the Safeguarding Therapeutics Act; Statement for the Record for House Committee on Energy & Commerce, Subcommittee on Consumer Protection & Commerce Hearing on Consumers Beware: Increased Risks During the COVID-19 Pandemic"; Statement on COVID-19 frauds and scams pertaining to medicines and medical supplies.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Health Issues
S.3548, CARES Act: To provide emergency assistance and health care response for individuals, families, and businesses affected by the 2020 coronavirus pandemic; Practice Support/Grants to Practice S.3599, Healthcare Workforce Resilience Act: Foreign physician immigration status H.R. 7059, Coronavirus Provider Protection Act: Liability protection for healthcare providers Public Law No: 116-142, Paycheck Protection Program Flexibility Act of 2020 S.3201, Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act: Letter to Congressional Leadership regarding Fentanyl S.2723, Mitigating Emergency Drug Shortages Act: reducing drug shortages H.R. 3502, Protecting People From Surprise Medical Bills Act: Surprise Medical Bills H.R. 2500, National Defense Authorization Act for Fiscal Year 2020: Krishnamoorthi amdt on drug shortages H.R. 3107, Improving Seniors' Timely Access to Care Act of 2019: pre-authorization S. 1895, Lower Health Care Costs Act H.R. 3692, Addiction Treatment Access Improvement Act of 2017: Medically assisted treatment; opioids H.R. 5761, Ending Maternal Mortality Act of 2018: Maternal mortality H.R. 5718, Perioperative Reduction of Opioids Act: Opioids H.R. 5197, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S. 2516, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S.2680, Opioid Crisis Response Act of 2018: Medically assisted treatment; opioids S.2456, CARA 2.0 Act of 2018: Medically assisted treatment; opioids H.R. 1565, Saving Lives, Saving Costs S.1475, Saving Lives, Saving Costs Comprehensive Addiction and Recovery Act of 2016 (PL 114-198) FY 2021 LHHS Appropriations: Fiscal Year 2021 Appropriations for Subcommittee on Labor, Health and Human Services Outside Witness Testimony Affordable Care Act reform efforts H.R. 1628, American Health Care Act of 2017 S. Amdt. 1030 to H.R. 1628, "Graham-Cassidy" Better Care Reconciliation Act of 2017 H.R. 1492, Medical Controlled Substances Transportation Act of 2017 H.R. 1215, Protecting Access to Care Act of 2017 H.R. 3545, Overdose Prevention and Patient Safety Act H.R. 3446, Restoring Board Immunity Act of 2017: Professional Licensing S.2260, Opioids and STOP Pain Initiative ACT:opioids 42 CFR Part 2, Confidentiality of Substance Use Disorder Patient Records: appropriate access to patient information essential for providing whole-person care H.R.3928, Truth in Healthcare Marketing Act of 2017 H.R. 1554, REDI Act: student loan debt repayment for residents 21st Century Cures Initiative Drug Shortages - FDA, DEA, HHS, CMS, GAO, House Energy and Commerce Committee, Senate HELP Committee DEA Scheduling Propofol Comparative Effectiveness Research - PCORI HITECH Implementation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Safe Use Initiative Pain Management FTC Letters to States re: Interventional Pain Medicine & Advanced Practice Nurses & Competition in Healthcare Anesthesia Research Funding (Pediatric and others) Scope of Practice FDA Operating Room Fires Naloxone FDA Opioids Prescription Drug Abuse FDA Network of Experts NIH Interagency Pain Research Coordinating Committee FDA SMART TOTS - pediatric anesthesia research USP - US Pharmacopeia National Pain Strategy Nondiscrimination Compounding FDA Nominations to Advisory Committees (Anesthesia Drugs, Anesthesia Devices, Compounding) Agency for Healthcare Research and Quality (AHRQ) funding Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Sequestration Opioids and opioid abuse; Brain health Certified Anesthesiologist Assistants Blood management COVID-19: Increased supply of PPE and ventilators, Funding for physician practices impacted by the cancellation of elective surgeries, unique role of anesthesiologists in responding to COVID-19 pandemic, medical liability, Scope of Practice (Waiver of federal supervision requirement under the Emergency Declaration), insurance moratorium; COVID Update Memorandum 4/21/20
Client expense: $330,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
2020 · second_quarter · Health Issues
S.3548, CARES Act: To provide emergency assistance and health care response for individuals, families, and businesses affected by the 2020 coronavirus pandemic; Practice Support/Grants to Practice H.R. 7059, Coronavirus Provider Protection Act: Liability protection for healthcare providers Public Law No: 116-142, Paycheck Protection Program Flexibility Act of 2020 S.3201, Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act: Letter to Congressional Leadership regarding Fentanyl Surprise Medical Bills S.2723, Mitigating Emergency Drug Shortages Act: reducing drug shortages H.R. 3502, Protecting People From Surprise Medical Bills Act H.R. 2500, National Defense Authorization Act for Fiscal Year 2020: Krishnamoorthi amdt on drug shortages H.R. 3107, Improving Seniors' Timely Access to Care Act of 2019: pre-authorization S. 1895, Lower Health Care Costs Act H.R. 3692, Addiction Treatment Access Improvement Act of 2017: Medically assisted treatment; opioids H.R. 5761, Ending Maternal Mortality Act of 2018: Maternal mortality H.R. 5718, Perioperative Reduction of Opioids Act: Opioids H.R. 5197, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S. 2516, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S.2680, Opioid Crisis Response Act of 2018: Medically assisted treatment; opioids S.2456, CARA 2.0 Act of 2018: Medically assisted treatment; opioids H.R. 1565, Saving Lives, Saving Costs S.1475, Saving Lives, Saving Costs Comprehensive Addiction and Recovery Act of 2016 (PL 114-198) FY 2021 LHHS Appropriations: Fiscal Year 2021 Appropriations for Subcommittee on Labor, Health and Human Services Outside Witness Testimony Affordable Care Act reform efforts H.R. 1628, American Health Care Act of 2017 S. Amdt. 1030 to H.R. 1628, "Graham-Cassidy" Better Care Reconciliation Act of 2017 H.R. 1492, Medical Controlled Substances Transportation Act of 2017 H.R. 1215, Protecting Access to Care Act of 2017 H.R. 3545, Overdose Prevention and Patient Safety Act H.R. 3446, Restoring Board Immunity Act of 2017: Professional Licensing S.2260, Opioids and STOP Pain Initiative ACT:opioids 42 CFR Part 2, Confidentiality of Substance Use Disorder Patient Records: appropriate access to patient information essential for providing whole-person care H.R.3928, Truth in Healthcare Marketing Act of 2017 H.R. 1554, REDI Act: student loan debt repayment for residents 21st Century Cures Initiative Drug Shortages - FDA, DEA, HHS, CMS, GAO, House Energy and Commerce Committee, Senate HELP Committee DEA Scheduling Propofol Comparative Effectiveness Research - PCORI HITECH Implementation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Safe Use Initiative Pain Management FTC Letters to States re: Interventional Pain Medicine & Advanced Practice Nurses & Competition in Healthcare Anesthesia Research Funding (Pediatric and others) Scope of Practice FDA Operating Room Fires Naloxone FDA Opioids Prescription Drug Abuse FDA Network of Experts NIH Interagency Pain Research Coordinating Committee FDA SMART TOTS - pediatric anesthesia research USP - US Pharmacopeia National Pain Strategy Nondiscrimination Compounding FDA Nominations to Advisory Committees (Anesthesia Drugs, Anesthesia Devices, Compounding) Agency for Healthcare Research and Quality (AHRQ) funding Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Sequestration Opioids and opioid abuse; Brain health Anesthesiologist Assistants Blood management COVID-19: Increased supply of PPE and ventilators,Funding for physician practices impacted by the cancellation of elective surgeries, unique role of anesthesiologists in responding to COVID-19 pandemic, medical liability, Scope of Practice (Waiver of federal supervision requirement under the Emergency Declaration), insurance moratorium; COVID Update Memorandum 4/21/20 Immigration: Foreign physician immigration status
Client expense: $380,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
2020 · second_quarter · Law Enforcement/Crime/Criminal Justice
S.Res 102, Second Chance Month Resolution; Public Law 115-391,First Step Act, implementation; S.3148/H.R.2935 Stopping Overdoses of Fentanyl Analogues Act; H.R. 5546, Effective Assistance of Counsel in the Digital Era Act; S. 2931, RE-ENTER Act, federal certificate of rehabilitation; H.R. 748, CARES Act, Sec. 12003, Section 15002 and DIVISION B (Federal Prison System, State and Local Law Enforcement Activities); FY2021 Commerce-Justice-Science and Related Agencies Appropriations, Second Chance Act and First Step Act Funding; S. 3201, Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act; H.R. 5078, Prison to Proprietorship Act; H.R. 5065, Prison to Proprietorship for Formerly Incarcerated Act; S. 3865 Paycheck Protection Program Second Chance Act; Phase Four COVID-19 relief legislation; Sentencing relief and Second Chance Act funding; S. 4034 , COVID-19 Safer Detention Act of 2020; S. 3895, JUSTICE Act; H.R. 7120, George Floyd Justice in Policing Act of 2020.
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2020 · first_quarter · Law Enforcement/Crime/Criminal Justice
S.1377, H.R. 2868, the Ensuring Quality Access to Legal (EQUAL) Defense Act, which would provide broad supports for indigent defense representation. H.R. 5546, the Effective Assistance of Counsel in the Digital Era Act, which would ensure that the attorney-client privilege applied to digital messages sent between federal prisoners and their lawyers. H.R.6414, the COVID-19 Correctional Facility Emergency Response Act of 2020, which would establish the Pandemic Jail and Prison Emergency Response grant program for states to encourage early and compassionate transfer of those incarcerated to home confinement. S.3201, the Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act, which would extend the current authority for prosecuting offenses involving such analogues while also preventing a consequent rise in the use of mandatory minimum sentences in connection with such cases. S. 1074, the Restoring Education and Learning Act of 2019 - concerning the restoration of Pell Grant eligibility for prisoners. H.R. 4018, a technical corrections bill to amend the Second Chance Act of 2007 to ensure that good time credits awarded to elderly inmates are included when the Bureau of Prisons calculates when the prisoner may be eligible to participate in the Elderly Offender Home Detention Pilot Program. H.R. 1585, Violence Against Women Reauthorization Act Activity in support of federal legislation concerning the sealing of criminal records and related information. Activity in support of authorizing judges to allow persons to remain free following a criminal conviction if the likely sentence would not include incarceration and the prosecution would not object. Activity in support of the greater use of Early and Compassionate Release to release inmates to home detention in response to the COVID-19 pandemic. Proposed changes to Customs and Border Protection Directive No. 3340-049 (Border Search of Electronic Devices Containing Information, dated August 20, 2009), Customs and Border Protection Directive No. 3340-049A (Border Search of Electronic Devices, dated January 4, 2018), and Immigration and Customs Enforcement Directive No. 7-6.1 (Border Searches of Electronic Devices, dated August 18, 2009) to prevent border officials from reading, duplicating, seizing, or sharing attorney-client privileged or confidential client documents or information contained on attorneys laptop computers, cell phones, and other electronic devices at U.S. border crossings unless the officials first obtain a subpoena based on reasonable suspicion or a warrant supported by probable cause Bureau of Consumer Financial Protection Proposed Rule on Amendments Relating to Disclosure of Records and Information; Docket No. CFPB-2016-0039; RIN 3170-AA63, 81 Fed. Reg. 58310 (August 24, 2016)-provisions (1) expanding the Bureaus discretion to share confidential information it receives from supervised and regulated entities with other foreign, state, and other governmental agencies and (2) prohibiting subjects of investigations and other recipients of civil investigative demands from disclosing information regarding the Bureaus investigation
2020 · first_quarter · Law Enforcement/Crime/Criminal Justice
H.R. 2348: Clean Slate Act. Full Bill Issues related to Certificates of Rehabilitation. Issues related to criminal justice reform. Issues related to grants to states to reform bail and fines and fees laws. S. 1622: Stopping Overdoses of Fentanyl Analogues Act. Full Bill S. 3148: Stopping Overdoses of Fentanyl Analogues Act. Full Bill S. 3201: Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act. Full Bill Issues related to eminent domain. Issues related to the television whitespace rule. S. 3398: EARN IT Act. Full Bill
Client expense: $550,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Office of Management & Budget (OMB), SENATE, White House Office
2020 · first_quarter · Law Enforcement/Crime/Criminal Justice
Support H.R. 5053, the Justice for Juveniles Act, which exempts youth up to the age of 21 from the requirements of the Prison Litigation Reform Act Support S. 3254 / HR 5717 , which creates a buy-back program for assault weapons Support full implementation of the Juvenile Justice Reform Act of 2018, including $80,000,000 to carry out programs under Title II state formula grants of the JJDPA; $96,053,401 to carry out programs under Title V of the JJDPA, of which, 11% goes to support the Tribal Youth Program; and the remaining $86.4 million goes to support the Title V PROMISE grants. Support the exclusion of mandatory minimums from the temporary extension of even trace amounts of illicit fentanyl and fentanyl analogues, and include a study on the impacts of this extended authority on public health and safety in S 3201 Support HR 4359, the PEACE Act, which would bar the use of deadly force unless necessary-- as a last resort-- to prevent imminent death or serious bodily injury, and reasonable alternatives have been exhausted. This standard is more restrictive than any current federal or state law Support the following for FY 21: $10 million for the Wrongful Conviction Review Program at the Department of Justice (DoJ), Bureau of Justice Assistance (the Wrongful Conviction Review Program is a part of the Capital Litigation Improvement Program); $10 million for the Kirk Bloodsworth Post-Conviction DNA Testing Program at the DoJ, National Institute of Justice (NIJ); $30 million for the Coverdell Forensic Sciences Improvement Grant Program at NIJ; $4.15 million to support forensic science standards setting activities at the National Institute of Standards and Technology (NIST); $15 million for NIST to support forensic science research and measurement science Oppose the "Trial penalty," which is a penalty of added incarceration time imposed on someone convicted of a crime for not agreeing to take a plea deal offered prior to trial Support $105 million for the Reintegration of Ex-Offenders (RExO) program, otherwise known as the Reentry Employment Opportunities (REO) program, within the Department of Labors Employment & Training Administration in the FY21 Labor, Health and Human Services, Education, and Related Agencies appropriations bill Support full funding for juvenile justice and delinquency prevention programs for Fiscal Year 2021. Specifically, we support $176 million dollars for Titles II & V of the Act in FY2021 budget Support S. 2146 / HR 3795, the Second Look Act, which would provide an opportunity for people serving long sentences to have their sentence reviewed by a federal judge and considered for release Oppose Cory Wilsons confirmation to the Judicial seat to the US District Court for the Southern District of Mississippi, based largely on his stated dislike of the ACA and healthcare provisions overall Support legislation to codify the Reentry Employment Opportunities (REO) Program, which currently exists as a pilot program authorized under the Workforce Innovation and Opportunity Act (WIOA). REO provides grants to organizations involved in workforce training, pre-apprenticeship, and apprenticeship programs for formerly incarcerated people, as well as those who will be released within six months Support the decarceration of prisons and jails. Specifically, using all available powers, including the powers of clemency, furlough, parole and compassionate release, dramatically reduce the prison and/or jail populations; working with local officials, advocate the maximum reduction in jail admissions; Working with local officials, advocate that local officials release the vast majority of individuals who are currently incarcerated in jails; for those individuals who remain incarcerated, ensure proper hygiene and access to medical care; for those individuals who remain incarcerated, facilitate communications home; and for everyone who has incurred debt and/or debt-related penalties, end the financial hardship associated with these debts and penalties Support requiring BOP, ICE, ORR and CPB to require a medical release or furlough to anyone who is high risk of becoming ill or is ill Support HR 5078, the Prison to Proprietorship, which directs the Small Business Administration, to require women's business centers and small-business development centers to provide entrepreneurship counseling and training services to individuals incarcerated in a minimum-, low-, or medium-security prison. Support HR 35, the Emmett Till Antilynching Act, which makes lynching a hate crime Oppose the nomination and confirmation of Judge Andrew Lynn Brasher to the US Court of Appeals for the 11th Circuit Support S 3190 / HR 5602, the Domestic Terrorism Prevention Act of 2020 which would enhance the federal governments efforts to prevent and solve crimes of domestic terrorism without adding new penalties
2020 · first_quarter · Law Enforcement/Crime/Criminal Justice
Facial recognition, Law enforcement access to digital evidence, law enforcement grants, Federal-state and local enforcement partnerships, bail reform and inmate release, encryption, H.R.1585 - Violence Against Women Reauthorization Act of 2019, S.2843 - Violence Against Women Reauthorization Act of 2019, mental health, substance abuse, homelessness, gun violence, violent crime, H.R. 748-CARES Act, H.R. 6021--Families First Coronavirus Response Act, COVID-19, H.R. 3735-Law Enforcement Suicide Data Collection Act, use of force policies, H.R. 6003-First Responder Resiliency Act, S. 3201-Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act, extreme risk protection orders, law enforcement intelligence training, NICS, S. 3398-EARN IT Act of 2020, Next Generation 911, H.R. 6390/S.3568-Medical Supply Chain Security Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), SENATE, White House Office
2020 · first_quarter · Immigration
Drug trafficking, violent crime, S. 3201-Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), SENATE, White House Office
2020 · first_quarter · Health Issues
S.3548, CARES Act: To provide emergency assistance and health care response for individuals, families, and businesses affected by the 2020 coronavirus pandemic; Practice Support/Grants to Practice S.3201, Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act: Letter to Congressional Leadership regarding Fentanyl Surprise Medical Bills S.2723, Mitigating Emergency Drug Shortages Act: reducing drug shortages H.R. 3502, Protecting People From Surprise Medical Bills Act H.R. 2500, National Defense Authorization Act for Fiscal Year 2020: Krishnamoorthi amdt on drug shortages H.R. 3107, Improving Seniors' Timely Access to Care Act of 2019: pre-authorization S. 1895, Lower Health Care Costs Act H.R. 3692, Addiction Treatment Access Improvement Act of 2017: Medically assisted treatment; opioids H.R. 5761, Ending Maternal Mortality Act of 2018: Maternal mortality H.R. 5718, Perioperative Reduction of Opioids Act: Opioids H.R. 5197, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S. 2516, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S.2680, Opioid Crisis Response Act of 2018: Medically assisted treatment; opioids S.2456, CARA 2.0 Act of 2018: Medically assisted treatment; opioids H.R. 1565, Saving Lives, Saving Costs S.1475, Saving Lives, Saving Costs Comprehensive Addiction and Recovery Act of 2016 (PL 114-198) FY 2021 LHHS Appropriations: Fiscal Year 2021 Appropriations for Subcommittee on Labor, Health and Human Services Outside Witness Testimony Affordable Care Act reform efforts H.R. 1628, American Health Care Act of 2017 S. Amdt. 1030 to H.R. 1628, "Graham-Cassidy" Better Care Reconciliation Act of 2017 H.R. 1492, Medical Controlled Substances Transportation Act of 2017 H.R. 1215, Protecting Access to Care Act of 2017 H.R. 3545, Overdose Prevention and Patient Safety Act H.R. 3446, Restoring Board Immunity Act of 2017: Professional Licensing S.2260, Opioids and STOP Pain Initiative ACT:opioids 42 CFR Part 2, Confidentiality of Substance Use Disorder Patient Records: appropriate access to patient information essential for providing whole-person care H.R.3928, Truth in Healthcare Marketing Act of 2017 H.R. 1554, REDI Act: student loan debt repayment for residents 21st Century Cures Initiative Drug Shortages - FDA, DEA, HHS, CMS, GAO, House Energy and Commerce Committee, Senate HELP Committee DEA Scheduling Propofol Comparative Effectiveness Research - PCORI HITECH Implementation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Safe Use Initiative Pain Management FTC Letters to States re: Interventional Pain Medicine & Advanced Practice Nurses & Competition in Healthcare Anesthesia Research Funding (Pediatric and others) Scope of Practice FDA Operating Room Fires Naloxone FDA Opioids Prescription Drug Abuse FDA Network of Experts NIH Interagency Pain Research Coordinating Committee FDA SMART TOTS - pediatric anesthesia research USP - US Pharmacopeia National Pain Strategy Nondiscrimination Compounding FDA Nominations to Advisory Committees (Anesthesia Drugs, Anesthesia Devices, Compounding) Agency for Healthcare Research and Quality (AHRQ) funding Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Sequestration Opioids and opioid abuse; Brain health Anesthesiologist Assistants Blood management Immigration: Foreign Physician Immigration Status COVID-19: Increased supply of PPE and ventilators,Funding for physician practices impacted by the cancellation of elective surgeries, unique role of anesthesiologists in responding to COVID-19 pandemic, medical liability, Scope of Practice (Waiver of federal supervision requirement under the Emergency Declaration)
2020 · first_quarter · Law Enforcement/Crime/Criminal Justice
S.Res 102, Second Chance Month Resolution; Public Law 115-391,First Step Act, implementation; S.3148/H.R.2935 Stopping Overdoses of Fentanyl Analogues Act; H.R. 5546, Effective Assistance of Counsel in the Digital Era Act; S. 2931, RE-ENTER Act, federal certificate of rehabilitation; H.R. 748, CARES Act, Sec. 12003, Section 15002 and DIVISION B (Federal Prison System, State and Local Law Enforcement Activities); FY2021 Commerce-Justice-Science and Related Agencies Appropriations, Second Chance Act and First Step Act Funding; S. 3201, Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act; H.R. 5078, Prison to Proprietorship Act; H.R. 5065, Prison to Proprietorship for Formerly Incarcerated Act.
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2020 · first_quarter · Law Enforcement/Crime/Criminal Justice
H.R. 3735, the "Law Enforcement Suicide Data Collection Act," legislation to require the Director of the FBI to provide information on suicide rates in law enforcement; entire bill. S. 2746, the "Law Enforcement Suicide Data Collection Act," legislation to require the Director of the FBI to provide information on suicide rates in law enforcement; entire bill. H.R. 5395, the "Back the Blue Act of 2019," legislation to revise Title 18, U.S. Code, to enhance protections for federal, state, and local law enforcement officers; entire bill. S. 1480, the "Back the Blue Act of 2019," legislation to revise Title 18, U.S. Code, to enhance protections for federal, state, and local law enforcement officers; entire bill. S. 3201, the "Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act," legislation to extend the DEA's temporary scheduling order for fentanyl-related substances; entire bill. H.R. 1156, the "LEOSA Reform Act," legislation to improve the Law Enforcement Officer Safety Act and provisions relating to the carrying of concealed weapons by law enforcement officers; entire bill. H.R. 1325, the "Protect and Serve Act of 2019," legislation to amend Title 18, U.S. Code, to punish criminal offenses targeting law enforcement officers; entire bill. S. 954, the "POWER Act," legislation to provide grants to state, local, territorial, and Tribal law enforcement agencies to purchase chemical screening devices and train personnel to use chemical screening devices in order to enhance law enforcement efficiency and protect law enforcement officers; entire bill. H.R. 6008, the "TBI and PTSD Law Enforcement Training Act," legislation to direct DOJ to develop crisis intervention training tools for use by first responders related to interacting with persons who have a traumatic brain injury or post-traumatic stress disorder, and to require the CDC to study and report on the incidence of TBI and PTSD in law enforcement; entire bill. Legislative proposal to improve the Law Enforcement Officer Safety Act and provisions relating to the carrying of concealed weapons by law enforcement officers (no bill introduced).
2020 · first_quarter · Law Enforcement/Crime/Criminal Justice
First Step Act oversight and implementation; REAL Act (S. 1074/H.R. 2168) - all provisions; NDAA; Ending Mass Collection of Americans' Phone Records Act (S. 936); Combatting Money Laundering, Terrorist Financing, and Counterfeiting Act of 2019 (S. 1883); FAIR Act (H.R. 1895); Effective Assistance of Counsel in the Digital Era Act (H.R. 5546); Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 (H.R. 2740); USA Freedom Act Reauthorization; Prohibiting Punishment of Acquitted Conduct Act (S. 2566); Second Look Act (S. 2146, H.R. 3795) - all provisions; Marijuana Opportunity Reinvestment and Expungement (MORE) Act (S.2227, H.R.3884) - all provisions; Stopping Overdoses of Fentanyl Analogues Act (SOFA) (S.1622, H.R. 2935) - all provisions; SHIELD Act (H.R. 2896); Mind Your Own Business Act of 2019 (S. 2637); federal parole; bill Re: elderly offender home detention & good time credits (H.R. 4018); Kenneth P. Thompson Begin Again Act (draft expungement bill); Federal Initiative to Guarantee Health by Targeting Fentanyl Act (S. 2701); Clean Slate Act (H.R. 2348); Reversing the Youth Tobacco Epidemic Act (H.R. 2339); Temporary Reauthorization and Study of the Emerging Scheduling of Fentanyl Analogues Act (S. 3201); State Justice Improvement Act (S. 3375, H.R. 606); Emergency Community Supervision Act; Compassionate release; EARN IT Act of 2020 (S. 3398); TRUST Act (Senate draft)
Client expense: $15,000 · Firm income: Not reported
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
DEBATE - The House proceeded with forty minutes of debate on S. 3201.
Considered under suspension of the rules. (consideration: CR H647-653)
Ms. Kuster (NH) moved to suspend the rules and pass the bill.
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Received in the House.
Message on Senate action sent to the House.
Introduced in the Senate, read twice, considered, read the third time, and passed without amendment by Unanimous Consent. (consideration: CR S261-262; text: CR S261-262)
Passed/agreed to in Senate: Introduced in the Senate, read twice, considered, read the third time, and passed without amendment by Unanimous Consent.
Introduced in Senate
| January 16, 2020 |
| Enrolled Bill | -- |
| Democratic |
| NH |
| Richard J. Durbin | Democratic | IL |
| Robert Menendez | Democratic | NJ |
Client expense: $160,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Congressional Budget Office (CBO), Consumer Financial Protection Bureau (CFPB), Education, Dept of, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Legal Services Corporation, Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
Client expense: $72,500 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Bureau of Alcohol Tobacco Firearms & Explosives, Bureau of Justice Assistance, Bureau of Prisons (BOP), Bureau of the Census, Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Education, Dept of, Election Assistance Commission (EAC), Employment & Training Administration, Equal Employment Opportunity Commission (EEOC), Federal Bureau of Investigation (FBI), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Institute of Standards & Technology (NIST), Office of Management & Budget (OMB), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Immigration & Customs Enforcement (ICE), Veterans Affairs, Dept of (VA), White House Office
Client expense: $340,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA)
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, White House Office
Government targets: Agriculture, Dept of (USDA), Education, Dept of, HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE